Blog

Stem Pharm enters exciting collaboration with Verge Genomics

Congratulations to Stem Pharm – a CTC client, SBIR Advance awardee and Wisconsin Innovation Award winner – on their recently announced collaboration to develop a disease model to validate novel targets identified by Verge Genomics for Parkinson’s disease (PD).

SBIR Advance Letters of Intent Due 4/11

As we start another round of SBIR Advance, I would like to remind you to watch the videos I have specifically for this program.